Andrew Hebert
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
-
- Cancer Mechanisms and Therapy
Papers in
- Oncology 5
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 1
-
- Cancer Mechanisms and Therapy 3
- Co-authors
- Mikhail Levit (5 shared papers)Natalia V. Malkova (2 shared papers)Alexei Protopopov (2 shared papers)Frank F. Sun (3 shared papers)Dmitri Wiederschain (2 shared papers)Jack Pollard (2 shared papers)Joachim Theilhaber (2 shared papers)Hongjing Qu (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)OncoImmunology (1 paper)JBI Evidence Synthesis (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesMexicoGermany
In The Last Decade
Andrew Hebert
5 papers receiving 66 citations
Peers
Comparison fields: 5 of 22
- Oncology 47
- Pathology and Forensic Medicine 21
- Immunology 19
- Toxicology 2
- Cancer Research 8
Countries citing papers authored by Andrew Hebert
This map shows the geographic impact of Andrew Hebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hebert more than expected).
Fields of papers citing papers by Andrew Hebert
This network shows the impact of papers produced by Andrew Hebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hebert. The network helps show where Andrew Hebert may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Hebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 45 | |
| 2 | 2018 | 7 | |
| 3 | 2020 | 7 | |
| 4 | 2017 | 5 | |
| 5 | 2020 | 2 | |
| 6 | 2023 | 0 |
About Andrew Hebert
Andrew Hebert is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Materials Chemistry and Organic Chemistry, having authored 6 papers that have together received 66 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (3 papers), Peptidase Inhibition and Analysis (3 papers), MXene and MAX Phase Materials (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), CAR-T cell therapy research (1 paper), Quinazolinone synthesis and applications (1 paper), Diabetic Foot Ulcer Assessment and Management (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Oncology (47 citations), Pathology and Forensic Medicine (21 citations), Immunology (19 citations), Toxicology (2 citations) and Cancer Research (8 citations). Andrew Hebert has collaborated with scholars based in United States, Mexico and Germany. Frequent co-authors include Mikhail Levit, Natalia V. Malkova, Alexei Protopopov, Frank F. Sun, Dmitri Wiederschain, Jack Pollard, Joachim Theilhaber, Hongjing Qu, Richard C. Gregory and Hui Qu. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, OncoImmunology, JBI Evidence Synthesis and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.